5-[(2S,6S,7E,9E)-13-(3-Furyl)-2,6,10-trimethyl-7,9-tridecadienylidene]-4-hydroxy-3-methylfuran-2(5H)-one

5-[(2S,6S,7E,9E)-13-(3-Furyl)-2,6,10-trimethyl-7,9-tridecadienylidene]-4-hydroxy-3-methylfuran-2(5H)-one Struktur
37905-12-7
CAS-Nr.
37905-12-7
Englisch Name:
5-[(2S,6S,7E,9E)-13-(3-Furyl)-2,6,10-trimethyl-7,9-tridecadienylidene]-4-hydroxy-3-methylfuran-2(5H)-one
Synonyma:
Fasciculatin;5-[(2S,6S,7E,9E)-13-(3-Furyl)-2,6,10-trimethyl-7,9-tridecadienylidene]-4-hydroxy-3-methylfuran-2(5H)-one;2(5H)-Furanone, 5-[(2S,6S,7E,9E)-13-(3-furanyl)-2,6,10-trimethyl-7,9-tridecadien-1-ylidene]-4-hydroxy-3-methyl-
CBNumber:
CB02296678
Summenformel:
C25H34O4
Molgewicht:
398.54
MOL-Datei:
37905-12-7.mol

5-[(2S,6S,7E,9E)-13-(3-Furyl)-2,6,10-trimethyl-7,9-tridecadienylidene]-4-hydroxy-3-methylfuran-2(5H)-one Eigenschaften

Aggregatzustand
Off-white to brown solid. May appear as oily solid.

Sicherheit

5-[(2S,6S,7E,9E)-13-(3-Furyl)-2,6,10-trimethyl-7,9-tridecadienylidene]-4-hydroxy-3-methylfuran-2(5H)-one Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Fasciculatin is a novel furanosesterterpene secondary marine metabolite. Maintains the ability to inhibit lymphocyte proliferation as well as acts as a cytotoxic agent.

5-[(2S,6S,7E,9E)-13-(3-Furyl)-2,6,10-trimethyl-7,9-tridecadienylidene]-4-hydroxy-3-methylfuran-2(5H)-one Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


5-[(2S,6S,7E,9E)-13-(3-Furyl)-2,6,10-trimethyl-7,9-tridecadienylidene]-4-hydroxy-3-methylfuran-2(5H)-one Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 15)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Energy Chemical 021-58432009 400-005-6266
marketing@energy-chemical.com China 44941 58

  • 5-[(2S,6S,7E,9E)-13-(3-Furyl)-2,6,10-trimethyl-7,9-tridecadienylidene]-4-hydroxy-3-methylfuran-2(5H)-one
  • Fasciculatin
  • 2(5H)-Furanone, 5-[(2S,6S,7E,9E)-13-(3-furanyl)-2,6,10-trimethyl-7,9-tridecadien-1-ylidene]-4-hydroxy-3-methyl-
  • 37905-12-7
Copyright 2019 © ChemicalBook. All rights reserved